GlassScriptPhysician profile
Daniel A Hoit
NPI 1902000698
$606,651.14
in general payments reported to CMS, 2019-2025
29 companies · $41K in 2025
The $41K reported for 2025 was more than what 94% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234K · 2020: $81K · 2021: $85K · 2022: $91K · 2023: $66K · 2024: $7,989 · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $24K · Acquisitions: $21K · Food and Beverage: $8,502.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $37,650.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24,730.00 |
| Travel and Lodging | $24,018.39 |
| Acquisitions | $20,693.85 |
| Food and Beverage | $8,502.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $369,403.00 | 2019-2025 | Web Aneurysm Embolization System, Stent, Lvis Junior |
| Stryker Corporation | $78,685.11 | 2019-2025 | Trevo, Surpass Evolve, Target |
| Medtronic, INC. | $66,127.28 | 2021-2025 | Catalyft Pl Expandable Interbody System, Pipeline, Intellis Adaptivestim |
| Medtronic USA, INC. | $61,808.49 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $13,097.31 | 2019-2025 | Artis Pheno |
| Sequent Medical, INC. | $8,400.00 | 2019 | |
| Imperative Care, INC | $2,384.63 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Reperfusion Catheter, Zoom Rdl Radial Access System, 103cm |
| Penumbra, INC. | $1,960.61 | 2019-2024 | Penumbra System, Red 72, Benchmark |
| Relievant Medsystems, INC. | $1,051.26 | 2023 | Intracept |
| Depuy Synthes Sales INC. | $840.16 | 2019-2025 | Trufill, Cerepak Uniform, Emboguard |
| Abbott Laboratories | $759.97 | 2023-2025 | Eterna, Proclaim |
| Rapid Medical LTD | $506.46 | 2022-2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Zimmer Biomet Holdings, INC. | $290.39 | 2019-2025 | Neuro Plating System, Evo Seeg Electrode |
| Balt USA, LLC | $202.05 | 2021-2022 | |
| Silk Road Medical, INC. | $188.66 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $142.22 | 2024 | |
| Boston Scientific Corporation | $134.38 | 2023-2025 | Wavewriter Alpha Prime 16, Cds - Mct/Cem Monitoring, Angiojet Ultra 5000a |
| Qapel Medical INC | $128.15 | 2023-2025 | |
| Centinel Spine, LLC | $102.76 | 2019 | |
| Globus Medical, INC. | $102.09 | 2025 | |
| Mivi Neuroscience, INC. | $74.63 | 2021 | |
| Scientia Vascular | $57.86 | 2022-2023 | |
| Route 92 Medical, INC. | $53.08 | 2025 | |
| Orthofix Medical, INC. | $43.19 | 2019 | |
| Amneal Pharmaceuticals LLC | $29.54 | 2019-2020 | |
| Mizuho America, INC. | $29.32 | 2020 | |
| Neurocrine Biosciences, INC. | $18.59 | 2022 | |
| Asahi Intecc USA, INC. | $15.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $14.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Hoit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.